Login
$AMLX
$27.67 -$0.13 (0.47%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Joshua Cohen Also a director
Co-Chief Executive Officer and Director
34 Since 2014
12 years
$2,719,807
Justin Klee Also a director
Co-Chief Executive Officer and Director
35 Since 2014
12 years
$2,719,807
James Frates
Chief Financial Officer
58 Since 2021
5 years
$1,375,327
Camille L. Bedrosian
Chief Medical Officer
73 Since 2023
3 years
$1,567,674
Gina M. Mazzariello
Chief Legal Officer and General Counsel
54 Since 2022
4 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Average tenure
7.1 years
from year joined
CEO also chairs the board
No
George Mclean Milne Jr., Ph.D.
Director Age On board Committees Other public boards 2025 pay Source
George Mclean Milne Jr., Ph.D.
82 2015
11 years
None stated None stated $218,578
Joshua Cohen
34 2014
12 years
None stated None stated Paid as CEO
Justin Klee
35 2014
12 years
None stated None stated Paid as CEO
Paul Fonteyne
64 2021
5 years
None stated None stated $168,578
Daphne Quimi
60 2021
5 years
audit · Chair
Century Therapeutics, Inc. (Nasdaq: IPSC) $173,578
Karen Firestone
70 2023
3 years
nominating and corporate governance
None stated $161,078
Bernhardt Zeiher, M.D.
62 2024
2 years
science and technology · Chair
Entrada Therapeutics, Inc. (Nasdaq: TRDA), Abeona Therapeutics Inc. (Nasdaq: ABEO) $166,078

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support